MCM
UTHR icon

MAI Capital Management’s United Therapeutics UTHR Stock Holding History

MAI Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
1,934
+874
+82% +$492K ﹤0.01% 949
2026
Q1 		$629K Buy
1,060
+564
+114% +$281K ﹤0.01% 938
2025
Q4 		$242K Sell
496
-27
-5% -$12.6K ﹤0.01% 1240
2025
Q3 		$219K Sell
523
-49
-9% -$16.5K ﹤0.01% 1235
2025
Q2 		$164K Buy
572
+81
+16% +$24.2K ﹤0.01% 1264
2025
Q1 		$151K Sell
491
-5
-1% -$1.71K ﹤0.01% 1229
2024
Q4 		$175K Buy
+496
New +$182K ﹤0.01% 1191
2014
Q2 		– Sell
-7,075
Closed -$665K – 416
2014
Q1 		$665K Sell
7,075
-440
-6% -$45K 0.07% 186
2013
Q4 		$850K Buy
7,515
+55
+0.7% +$4.96K 0.09% 155
2013
Q3 		$588K Hold
7,460
– – 0.08% 170
2013
Q2 		$491K Buy
+7,460
New +$481K 0.06% 181

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MAI Capital Management's UTHR Position: Q2 2026 in Review

MAI Capital Management increased its United Therapeutics (UTHR) stake by 82% in Q2 2026, buying an estimated $492K and bringing the position to 1,934 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #949.

MAI Capital Management first reported a position in UTHR in Q2 2013 and has held it in 11 quarters since. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • MAI Capital Management held 1,934 shares of United Therapeutics worth $1.05M as of Q2 2026.
  • MAI Capital Management bought 874 United Therapeutics shares in Q2 2026, an estimated $492K.
  • United Therapeutics made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #949 holding.
  • MAI Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 11 quarters since.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.